Literature DB >> 29546996

Future Research Directions in Pneumonia. NHLBI Working Group Report.

Charles S Dela Cruz1, Richard G Wunderink2, David C Christiani3,4, Stephania A Cormier5, Kristina Crothers6, Claire M Doerschuk7,8, Scott E Evans9, Daniel R Goldstein10,11,12, Purvesh Khatri13, Lester Kobzik3, Jay K Kolls14, Bruce D Levy15, Mark L Metersky16, Michael S Niederman17, Roomi Nusrat18, Carlos J Orihuela19, Paula Peyrani20, Alice S Prince21, Julio A Ramírez20, Karen M Ridge2, Sanjay Sethi22, Benjamin T Suratt23, Jacob I Sznajder2, Ephraim L Tsalik24,25, Allan J Walkey26, Sachin Yende27,28, Neil R Aggarwal29, Elisabet V Caler29, Joseph P Mizgerd26.   

Abstract

Pneumonia is a complex pulmonary disease in need of new clinical approaches. Although triggered by a pathogen, pneumonia often results from dysregulations of host defense that likely precede infection. The coordinated activities of immune resistance and tissue resilience then dictate whether and how pneumonia progresses or resolves. Inadequate or inappropriate host responses lead to more severe outcomes such as acute respiratory distress syndrome and to organ dysfunction beyond the lungs and over extended time frames after pathogen clearance, some of which increase the risk for subsequent pneumonia. Improved understanding of such host responses will guide the development of novel approaches for preventing and curing pneumonia and for mitigating the subsequent pulmonary and extrapulmonary complications of pneumonia. The NHLBI assembled a working group of extramural investigators to prioritize avenues of host-directed pneumonia research that should yield novel approaches for interrupting the cycle of unhealthy decline caused by pneumonia. This report summarizes the working group's specific recommendations in the areas of pneumonia susceptibility, host response, and consequences. Overarching goals include the development of more host-focused clinical approaches for preventing and treating pneumonia, the generation of predictive tools (for pneumonia occurrence, severity, and outcome), and the elucidation of mechanisms mediating immune resistance and tissue resilience in the lung. Specific areas of research are highlighted as especially promising for making advances against pneumonia.

Entities:  

Keywords:  bacterial infection; host response; host susceptibility; pneumonia; viral infection

Mesh:

Year:  2018        PMID: 29546996      PMCID: PMC6058989          DOI: 10.1164/rccm.201801-0139WS

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  71 in total

1.  Medium-term survival after hospitalization with community-acquired pneumonia.

Authors:  Grant W Waterer; Lori A Kessler; Richard G Wunderink
Journal:  Am J Respir Crit Care Med       Date:  2003-12-23       Impact factor: 21.405

2.  Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling.

Authors:  Luis F Reyes; Marcos I Restrepo; Cecilia A Hinojosa; Nilam J Soni; Antonio Anzueto; Bettina L Babu; Norberto Gonzalez-Juarbe; Alejandro H Rodriguez; Alejandro Jimenez; James D Chalmers; Stefano Aliberti; Oriol Sibila; Vicki T Winter; Jacqueline J Coalson; Luis D Giavedoni; Charles S Dela Cruz; Grant W Waterer; Martin Witzenrath; Norbert Suttorp; Peter H Dube; Carlos J Orihuela
Journal:  Am J Respir Crit Care Med       Date:  2017-09-01       Impact factor: 21.405

3.  Proportion and Cost of Unplanned 30-Day Readmissions After Sepsis Compared With Other Medical Conditions.

Authors:  Florian B Mayr; Victor B Talisa; Vikram Balakumar; Chung-Chou H Chang; Michael Fine; Sachin Yende
Journal:  JAMA       Date:  2017-02-07       Impact factor: 56.272

Review 4.  Predictors of treatment failure and clinical stability in patients with community acquired pneumonia.

Authors:  Deirdre Morley; Antoni Torres; Catia Cillóniz; Ignacio Martin-Loeches
Journal:  Ann Transl Med       Date:  2017-11

Review 5.  The Intersection of Aging Biology and the Pathobiology of Lung Diseases: A Joint NHLBI/NIA Workshop.

Authors:  G R Scott Budinger; Ronald A Kohanski; Weiniu Gan; Michael S Kobor; Luis A Amaral; Mary Armanios; Karl T Kelsey; Annie Pardo; Rubin Tuder; Fernando Macian; Navdeep Chandel; Douglas Vaughan; Mauricio Rojas; Ana L Mora; Elizabeth Kovacs; Steven R Duncan; Toren Finkel; Augustine Choi; Oliver Eickelberg; Danica Chen; Alvar Agusti; Moises Selman; William E Balch; Paula Busse; Anning Lin; Richard Morimoto; Jacob I Sznajder; Victor J Thannickal
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2017-10-12       Impact factor: 6.053

Review 6.  Severity assessment scores to guide empirical use of antibiotics in community acquired pneumonia.

Authors:  Aran Singanayagam; James D Chalmers
Journal:  Lancet Respir Med       Date:  2013-06-27       Impact factor: 30.700

7.  Susceptibility to Childhood Pneumonia: A Genome-Wide Analysis.

Authors:  Lystra P Hayden; Michael H Cho; Merry-Lynn N McDonald; James D Crapo; Terri H Beaty; Edwin K Silverman; Craig P Hersh
Journal:  Am J Respir Cell Mol Biol       Date:  2017-01       Impact factor: 6.914

Review 8.  Immune mechanisms of respiratory viral infections in asthma.

Authors:  Hugo A Farne; Sebastian L Johnston
Journal:  Curr Opin Immunol       Date:  2017-08-14       Impact factor: 7.486

9.  Elevated hemostasis markers after pneumonia increases one-year risk of all-cause and cardiovascular deaths.

Authors:  Sachin Yende; Gina D'Angelo; Florian Mayr; John A Kellum; Lisa Weissfeld; A Murat Kaynar; Tammy Young; Kaikobad Irani; Derek C Angus
Journal:  PLoS One       Date:  2011-08-10       Impact factor: 3.240

10.  Lung microbiome and host immune tone in subjects with idiopathic pulmonary fibrosis treated with inhaled interferon-γ.

Authors:  Jing Wang; Melissa Lesko; Michelle H Badri; Bianca C Kapoor; Benjamin G Wu; Yonghua Li; Gerald C Smaldone; Richard Bonneau; Zachary D Kurtz; Rany Condos; Leopoldo N Segal
Journal:  ERJ Open Res       Date:  2017-07-12
View more
  26 in total

Review 1.  Inflammation and Pneumonia: Why Are Some More Susceptible than Others?

Authors:  Joseph P Mizgerd
Journal:  Clin Chest Med       Date:  2018-12       Impact factor: 2.878

Review 2.  Host-Pathogen Interactions in Gram-Positive Bacterial Pneumonia.

Authors:  Jennifer A Grousd; Helen E Rich; John F Alcorn
Journal:  Clin Microbiol Rev       Date:  2019-05-29       Impact factor: 26.132

3.  Pneumonia: host susceptibility and shared genetics with pulmonary function and other traits.

Authors:  M B Khadzhieva; A N Kuzovlev; L E Salnikova
Journal:  Clin Exp Immunol       Date:  2019-10-01       Impact factor: 4.330

4.  Pneumonia recovery reprograms the alveolar macrophage pool.

Authors:  Antoine Guillon; Emad I Arafa; Kimberly A Barker; Anna C Belkina; Ian Martin; Anukul T Shenoy; Alicia K Wooten; Carolina Lyon De Ana; Anqi Dai; Adam Labadorf; Jaileene Hernandez Escalante; Hans Dooms; Hélène Blasco; Katrina E Traber; Matthew R Jones; Lee J Quinton; Joseph P Mizgerd
Journal:  JCI Insight       Date:  2020-02-27

5.  Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia.

Authors:  James M Walter; Ziyou Ren; Tyrone Yacoub; Paul A Reyfman; Raj D Shah; Hiam Abdala-Valencia; Kiwon Nam; Vince K Morgan; Kishore R Anekalla; Nikita Joshi; Alexandra C McQuattie-Pimentel; Ching-I Chen; Monica Chi; SeungHye Han; Francisco J Gonzalez-Gonzalez; Saul Soberanes; Raul P Aillon; Satoshi Watanabe; Kinola J N Williams; Ziyan Lu; Joseph Paonessa; Peter Hountras; Madonna Breganio; Nicole Borkowski; Helen K Donnelly; Jonathan P Allen; Luis A Amaral; Ankit Bharat; Alexander V Misharin; Neda Bagheri; Alan R Hauser; G R Scott Budinger; Richard G Wunderink
Journal:  Am J Respir Crit Care Med       Date:  2019-05-15       Impact factor: 21.405

6.  Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia.

Authors:  Catia Cillóniz; Adamantia Liapikou; Ignacio Martin-Loeches; Carolina García-Vidal; Albert Gabarrús; Adrian Ceccato; Daniel Magdaleno; Josep Mensa; Francesc Marco; Antoni Torres
Journal:  PLoS One       Date:  2018-07-18       Impact factor: 3.240

Review 7.  Surviving Deadly Lung Infections: Innate Host Tolerance Mechanisms in the Pulmonary System.

Authors:  Meredith J Crane; Kayla M Lee; Ethan S FitzGerald; Amanda M Jamieson
Journal:  Front Immunol       Date:  2018-06-22       Impact factor: 7.561

Review 8.  Dual Role of Hydrogen Peroxide as an Oxidant in Pneumococcal Pneumonia.

Authors:  Mobarak Abu Mraheil; Haroldo A Toque; Luigi La Pietra; Juerg Hamacher; Tenzing Phanthok; Alexander Verin; Joyce Gonzales; Yunchao Su; David Fulton; Douglas C Eaton; Trinad Chakraborty; Rudolf Lucas
Journal:  Antioxid Redox Signal       Date:  2020-08-14       Impact factor: 8.401

9.  Estrogen Alleviates Sex-Dependent Differences in Lung Bacterial Clearance and Mortality Secondary to Bacterial Pneumonia after Traumatic Brain Injury.

Authors:  Jean-Francois Pittet; Parker J Hu; Jaideep Honavar; Angela P Brandon; Cilina A Evans; Rebekah Muthalaly; Qiang Ding; Brant M Wagener
Journal:  J Neurotrauma       Date:  2020-12-29       Impact factor: 5.269

Review 10.  Lipid-Derived Mediators are Pivotal to Leukocyte and Lung Cell Responses in Sepsis and ARDS.

Authors:  Julie Nijmeh; Bruce D Levy
Journal:  Cell Biochem Biophys       Date:  2021-06-27       Impact factor: 2.194

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.